Development and internal validation of a nomogram predicting 3-year chronic kidney disease upstaging following robot-assisted partial nephrectomy.

Journal: International urology and nephrology
PMID:

Abstract

PURPOSE: Aim of the present study was to develop and validate a nomogram to accurately predict the risk of chronic kidney disease (CKD) upstaging at 3 years in patients undergoing robot-assisted partial nephrectomy (RAPN).

Authors

  • Rocco Simone Flammia
    Department of Maternal-Infant and Urological Sciences, Sapienza University/Policlinico Umberto I, Rome, Italy.
  • Umberto Anceschi
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. Electronic address: umberto.anceschi@gmail.com.
  • Gabriele Tuderti
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Fabrizio Di Maida
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Antonio Andrea Grosso
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Luca Lambertini
    Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Andrea Mari
  • Riccardo Mastroianni
    Complex Operative Unit of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Alfredo Bove
    Department of Urology, Regina Elena Institute, Rome, Italy.
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Jennifer Lee
    Department of Nutritional Sciences, Temerty Faculty School of Medicine, University of Toronto, Toronto, ON, Canada.
  • Savio D Pandolfo
    Division of Urology, VCU Health, Richmond, VA, USA.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Daniel Eun
    Department of Urology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
  • Riccardo Autorino
    Department of Urology, Rush University, Chicago, IL, USA.
  • Costantino Leonardo
    Department of Urology, La Sapienza University, Rome, Italy.
  • Giuseppe Simone
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.